新型冠狀病毒感染疾病 (COVID-19) 疫苗:受託開發製造趨勢

本報告提供新型冠狀病毒感染疾病 (COVID-19) 疫苗的受託開發製造趨勢調查，開發中的COVID-19疫苗的類型、技術，臨床試驗趨勢，受託開發製造的能力，契約概要，投資者、資金來源，價值鏈等的現狀彙整。

目錄

第1章 摘要整理

第2章 進入經營者

第3章 技術概要

• 所謂COVID-19
• 開發中的COVID-19疫苗的類型、技術

第4章 趨勢

第5章 產業分析

• 開發中的COVID-19疫苗
• COVID-19疫苗的銷售額預測
• 疫苗的受託製造能力
• COVID-19疫苗的受託服務契約
• COVID-19疫苗製造的投資家
  • 政府
  • 製藥企業
  • CMO

第6章 價值鏈

第7章 企業

第8章 附錄

第9章 關於作者

This expert trend report is a comprehensive look at the contract manufacturing landscape surrounding COVID-19 Vaccine in 2020, including analysis of pipeline drugs, clinical trials, CMO activity, Contract Manufacturing Service Agreements, and funding for manufacturing of COVID-19 Vaccines. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

Scope

This report gives an important expert quantitative analysis on the COVID-19 contract vaccine manufacturing industry.

• Findings are based on the industry's most comprehensive database of the Pharma industry (GlobalData's Pharma Intelligence Center). The 11 tables and 23 figures throughout the report illustrate major points and trends.

Reasons to Buy

• What are the pipeline COVID-19 prophylactic vaccines by developer type?
• What are the top pipeline COVID-19 prophylactic vaccines analyst consensus sales forecast?
• What is the distribution of COVID-19 prophylactic vaccines clinical trials?
• What and Where are CMOs vaccine manufacturing facilities?
• What are the COVID-19 vaccine contract manufacturing service agreements by Molecule Type?
• What are the COVID-19 vaccine contract manufacturing service agreements by Service?
• What are the COVID-19 vaccine contract manufacturing service agreements by CMO?
• What are the COVID-19 vaccine contract manufacturing service agreements by Sponsor?

Table of Contents

Table of Contents

1 Executive Summary

2 Players

3 Technology Briefing

• 3.1 What is COVID-19?
• 3.2 COVID-19 Pipeline Vaccine Types and Technology

4 Trends

5 Industry Analysis

• 5.1 COVID-19 Pipeline Vaccines
• 5.2 COVID-19 Vaccine Projected Sales
• 5.3 Contract Manufacturing Capabilities for Vaccines
• 5.4 COVID-19 Vaccine Contract Service Agreements
• 5.5 Investors in COVID-19 Vaccine Manufacturing
  • 5.5.1 Governments
  • 5.5.2 Pharma Companies
  • 5.5.3 CMOs

6 Value Chain

7 Companies

8 Appendix

• 8.1 Methodology
• 8.2 Bibliography
• 8.3 Primary Research - Key Opinion Leaders
• 8.4 Further Reading

9 About the Authors

List of Tables

List of Tables

• Table 1: COVID-19 Vaccine Trends, 2020
• Table 2: Highest Development (Phase II-Marketed) COVID-19 Vaccines, 2020
• Table 3: Likelihood of Approval for Infectious Disease Vaccines, 2020
• Table 4: Promising COVID-19 Vaccines with Fast Track, WARP, ESI and Rolling Submission Status 2020
• Table 5: COVID-19 Vaccine Contract Manufacturing Service Agreements, 2020
• Table 6: Government and Non-Governmental Organization Funding Announcements, 2020
• Table 7: Pharma Funding Events, 2020
• Table 8: CMO Funding Events, 2020
• Table 9: CMOs with COVID-19 Vaccine Contract Service Agreements
• Table 10: Pharma Company Sponsors with COVID-19 Vaccine Pipeline Drugs
• Table 11: Further Reading

List of Figures

List of Figures

• Figure 1: Leading Players for COVID-19 Vaccine Manufacturing and their Place on the Value Chain
• Figure 2: COVID-19 Virus Life Cycle
• Figure 3: Top COVID-19 Vaccine Trends, 2020
• Figure 4: COVID-19 Pipeline Vaccines by Highest Phase, 2020
• Fig